Dr. Criscione has a Ph.D. in Biomedical Engineering and an M.D., both from Johns Hopkins University. He completed a post-doctoral fellowship in the Department of Cardiology at University of California at San Diego; and in 2001, joined the faculty of the Department of Biomedical Engineering at Texas A&M University. He is a leading expert on the role of mechanical stimuli in heart disease and heart recovery, and he is the inventor of CRK therapy and CorAmend ^TM. This is his first commercial venture; yet as the director of the cardiac mechanics laboratory, he has management experience. He has proven himself as an effective grant writer and as paradigm shifter who does not give up and who can lead a scientific field in a new direction. For example, he recently proved, in the Journal of Elasticity, that the conventional approach for describing high strain materials was ill-conceived experimentally. The mechanics community was not ready to accept that 50 years worth of analysis was flawed; but despite multiple rejections and controversial presentations, Dr. Criscione persevered and forever changed how the behaviors of materials such as latex and polyurethane are described quantitatively.

Mr. Hall worked in the medical device industry for over 25 years with a Fortune 100 company.  While in industry, he held various positions of increasing responsibility and was responsible for the launch and support of many medical device products, cost improvement projects, process development issues, and finally licensing, acquisition and divestiture.  He has managed medical device projects and was responsible for launching products internationally as well as in the United States.  Mr. Hall earned a B.A. degree from Sterling College (chemistry), received his M.S. degree from Kansas State University (organometallic chemistry). He subsequently earned an M.B.A. from Southern Illinois University at Edwardsville. Mr. Hall has served on a number of start-up company boards ranging from diagnostic companies to software companies.

 

Dr. Robbins has 25 years experience in the semiconductor industry and held a variety of management and executive roles at Texas Instruments. From 1997 through 2000, as a Vice President of Texas Instruments, he managed the worldwide manufacturing operations for TI’s analog and mixed-signal products, with ten factories worldwide, and a workforce of over 9,000, supporting $4B/yr revenue.  Previously, he managed an R&D project targeted at the flat-panel display market, and was a member of the Board of Directors of the U.S. Display Consortium.  Other roles include acquisition/integration manager for the acquisition of Silicon Systems Incorporated (SSi) by TI, a $600M acquisition, Product Department Manager for TI’s analog and mixed-signal ICs, with responsibility for design engineering, product engineering, production planning, and P&L, with a worldwide revenue base of $400M/yr, and QRA Manager for TI's Volume Products (all Analog and Logic products).  He retired from Texas Instruments in January 2001 to pursue interests in the area of startup companies.  In addition to his role with Techpiphany, he is has recently served on the boards of directors and advisory boards of various companies, and is currently on the board of MAI Logic, a Fremont CA based company.  Mr. Robbins holds a Ph.D. in Solid State Physics from Arizona State University (1976).  He also holds an M.S. in Physics (Arizona State University, 1973) and a B.A. in Physics (DePauw University, 1971).  His research was in the field of Raman Scattering.